An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity

European Journal of Pharmacology
Sudha DesaiMaret J Panzenbeck

Abstract

Cathepsin S is a major histocompatibility complex (MHC) class II associated invariant chain (Ii) degrading enzyme expressed in antigen presenting cells such as B cells and dendritic cells. This enzyme is essential for MHC class II associated antigen processing and presentation to CD4(+) T cells. Compound I, a selective, reversible and orally bioavailable, inhibitor of cathepsin S, with molecular IC(50)=9 nM, has been recently described. We have tested the effects of compound I in a trans vivo model of delayed-type hypersensitivity. Human peripheral blood mononuclear cells (7-10 x 10(6)) from tetanus-sensitized donors were co-injected with tetanus toxoid (0.25 Lf) into C57Bl/6 mouse footpads. At 24 h, significant footpad swelling (+0.024+/-0.001 cm) characterized by an influx of mouse neutrophils and monocytes was observed. Injection of peripheral blood mononuclear cells alone caused negligible swelling (0.002+/-0.0002 cm). Anti-human MHC class II (HLA-DR, DP, DQ) antibody (5 mg/kg, i.p.) inhibited the swelling 91+/-7%, thus demonstrating a role of human antigen presenting cells in this model. Compound I (10, 30, and 100 mg/kg, p.o.) inhibited the response with an ED50 of approximately 18 mg/kg. Compound III, a less active analo...Continue Reading

References

Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·V Y ReddyS J Weiss
Apr 2, 1998·Current Opinion in Immunology·H A Chapman
Aug 10, 1999·Human Immunology·L CarrodeguasA M VanBuskirk
Jan 13, 2000·Immunological Reviews·J A VilladangosH L Ploegh
Jan 13, 2000·Immunological Reviews·T Y Nakagawa, A Y Rudensky
Feb 7, 2001·Immunity·J A Villadangos, H L Ploegh
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Dec 3, 2002·Journal of Medicinal Chemistry·Yancey D WardMarc Giradot
Jan 23, 2003·Bioorganic & Medicinal Chemistry·Charles L CywinDenice M Spero
Feb 26, 2003·Circulation Research·G-P ShiP Libby
Mar 18, 2003·The Journal of Clinical Investigation·Galina K SukhovaGuo-Ping Shi
Jun 24, 2003·The American Journal of Pathology·Thomas FlanneryPatrick G Johnston
Oct 21, 2003·The Journal of Pharmacology and Experimental Therapeutics·Robin L ThurmondLars Karlsson

❮ Previous
Next ❯

Citations

Apr 16, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Naoto MinematsuAkitoshi Ishizaka
Aug 9, 2006·Experimental Eye Research·Eunok Im, Andrius Kazlauskas
Feb 14, 2008·Expert Opinion on Therapeutic Targets·Suman GuptaAbhijit Ray
Jun 16, 2015·PloS One·Euan Ramsay Orr Allan, Robin Michael Yates

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.